Biotech investing is inherently volatile, making it a high-stakes venture suited only for those with a high-risk tolerance. Despite the volatility, this sector holds the potential for significant returns when investments are timed correctly. Notably, the biotech stocks featured on our site recently achieved their 52-week highs as of yesterday.
*Note: Last Closing Price refers to the stock's closing price as of September 19, 2024.
**Related Reading:**
"ACLX and HROW Deliver Triple-Digit Returns - Did You Cash In?"
